MediFind Launches AI-Powered Chatbot to Help Patients Find the Right Provider

In July 2026, MediFind launched AI-Powered Chatbot Chloe, a new Find the Right Provider chatbot. This launch is designed to guide patients step by step through the process of finding a provider who fits their needs. It also eliminates common care-seeking challenges like navigating insurance and finding availability.

Meet Chloe: Your AI Guide to Finding the Perfect Doctor

Finding the right doctor for chronic conditions, specialist referrals, or rare diseases can be overwhelming. Patients often struggle with insurance coverage, provider availability, and new patient requirements. Chloe, from MediFind, simplifies this process by collecting relevant patient information and facilitating tailored provider matches from a database of over 2 million clinicians.

When patients access Chloe on MediFind.com, they go through a brief intake process, answering questions about their care needs, location, insurance, and preferences. By guiding patients through the process and capturing the right details up front with AI-powered features, the tool makes it easier to find a provider who fits and book with more confidence. The chatbot then offers suitable providers, allowing patients to review profiles and request appointments directly through the platform.

David Linetsky, President of Phreesia Network Solutions, also stated that "We built Chloe to provide guidance, not just search results”. Access to the right specialist is a significant hurdle in healthcare, and MediFind’s advanced analytics, combined with Chloe’s personalized experience, improves the search for providers, especially for those with complex, chronic, and rare conditions.

Significance and Future Perspective

Chloe is shifting the patient experience into a guided, empowered journey, bringing personalized experience to patients managing complex, chronic, and rare conditions. By eliminating provider-matching friction, verifying directory data, which further resolves global industry issues with unverified or outdated provider directories, and streamlining specialist discovery, this digital gateway acts as an intelligent digital gateway, empowering patients to overcome typical hurdles and take active ownership of their healthcare.

As the technology scales, future iterations of AI assistants on the platform will assist patients in enrolling in clinical trials. Medical chatbots may increase patient interactions for diagnostics, transforming initial healthcare spending, and will encourage integration with diagnostics. Upcoming developments may include features such as Second Opinion Finder to help patients verify diagnoses and explore treatments.

Impact on the Healthcare Industry

This AI-powered chatbot, Chloe, has a positive impact on the healthcare industry by transforming access by guiding patients through a conversational intake to match them with specialized providers, insurance plans, and locations, streamlining provider discovery, and preventing patients from abandoning their search.

Chloe improved patient activation by encouraging patients to actively participate in their care via a personalized experience, especially for those with complex conditions. By capturing patient demands upfront, it also streamlines administrative processes and avoids booking errors to reduce administrative burden.  The chatbot connects patients to leading experts and clinical trials using its global medical analytics. Concurrently, it also simplifies healthcare directories by enabling users to navigate and book appointments securely.

It also addresses healthcare industry hurdles by navigating complex provider directories, leveraging advanced analytics to overcome specialist shortages, and synthesizing global data to lower information overload for patients. This approach also streamlines the search for care, avoiding patients being overwhelmed by inaccurate options.

Impact of Generative AI in the Healthcare Industry

The global generative AI in healthcare market size is valued at USD 2.64 billion in 2025 and is predicted to increase from USD 3.57 billion in 2026 to approximately USD 48.23 billion by 2035, expanding at a CAGR of 33.71% from 2026 to 2035.

According to Precedence Research, Chloe impacts Generative AI in the healthcare space by linking up vast AI datasets and actionable patient navigation, particularly for patients those managing chronic or rare conditions.

Many patients abandon their search due to incorrect bookings, and Chloe navigates insurance, provider availability, and specific care demands to ensure accurate patient-provider matches. It reduces the operational burden on clinic staff by automating the initial intake and triage process to focus more on direct patient care. It also overcomes the challenges of general generative models by anchoring its intake process in verified, evidence-based data. It leverages advanced analytics to democratize access to care by surfacing tailored provider matches and clinical trials.

About MediFind

MediFind, a data-powered online provider directory offered by Phreesia, leverages AI and research-backed data to assist patients with complex, chronic, or rare diseases in quickly locating top specialists and treatment advancements. By emphasizing objective clinical expertise over user reviews, the service primarily aims to bridge individuals with expert care and enhance treatment timelines.

MediFind provides data-driven health tools to empower patients at every step of their medical journey. Its core services include a Condition Search for symptom and disease analysis, the Expert Finder to locate global specialists, the Second Opinion Finder for alternative insights, a Clinical Trials tool, and AI-powered chatbots for optimized provider booking.